Older patients with LBCL show comparable outcomes to younger patients and product-specific profiles in CAR-T therapy

This publication has 34 references indexed in Scilit:

• Anti‐CD19 chimeric antigen receptor T‐cell therapy in older patients with relapsed or refractory large B‐cell lymphoma: A multicenter study
  American Journal of Hematology, 2024
• Chimeric antigen receptor‐T cell therapy shows similar efficacy and toxicity in patients with diffuse large B‐cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study
  HemaSphere, 2024
• Safety and efficacy of tisagenlecleucel in patients with relapsed or refractory B-cell lymphoma: the first real-world evidence in Japan
  International Journal of Clinical Oncology, 2023
• Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter Analysis
  Transplantation and Cellular Therapy, 2021
• ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
  Transplantation and Cellular Therapy, 2019
• Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell Therapy
  Transplantation and Cellular Therapy, 2019
• The Impact of Advanced Patient Age on Mortality after Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma: A Retrospective Study by the European Society for Blood and Marrow Transplantation Lymphoma Working Party
  Transplantation and Cellular Therapy, 2019
• Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
  CNS Drugs, 2018
• High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Elderly Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma: A Nationwide Retrospective Study
  Transplantation and Cellular Therapy, 2014
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators
  Statistics in Medicine, 1999